Pulse Biosciences (PLSE) is scheduled to report Q3 earnings on November 4, 2026. Analysts estimate EPS of $-0.31 and quarterly revenue of $600K.
In the most recent quarter (Q2), Pulse Biosciences reported EPS of $-0.36, missing estimates of $-0.29 by 0.24%. Revenue came in at $434K, missing the estimate of $566.66K by 0.23%.
Pulse Biosciences has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Pulse Biosciences has averaged an EPS surprise of 0.12% and a revenue surprise of 0.29%.
Earnings Date
Nov 4
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$600K
Annual Revenue
$1.19M
as of Jun 30
Analyze the earnings history of Pulse Biosciences using advanced sorting and filters.
The chart below shows Pulse Biosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Pulse Biosciences's reported revenue compared to analyst estimates over recent quarters.
Pulse Biosciences (PLSE) is scheduled to report earnings on November 4, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
The Actual EPS was $-0.36, which missed the estimate of $-0.29.
The Actual Revenue was $434K, which missed the estimate of $566.66K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.36 | $-0.29 | -24.1 % |
| Q1 | May 4, 2026 | $-0.27 | $-0.24 | -12.5 % |
| Q4 | Feb 19, 2026 | $-0.26 | $-0.25 | -4.00 % |
| Q3 | Nov 5, 2025 | $-0.29 | $-0.31 | 6.45 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $434.00K | $566.66K | -23.4 % |
| Q1 | May 4, 2026 | $401.00K | $420.00K | -4.52 % |
| Q4 | Feb 19, 2026 | $264.00K | $250.00K | 5.60 % |
| Q3 | Nov 5, 2025 | $86.00K | $500.00K | -82.8 % |